Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Cancer Research in Fiscal Year 2009

This page contains a list of citations for journal articles authored by staff members of CDC's Division of Cancer Prevention and Control (DCPC) during fiscal year 2009, which began October 1, 2008 and will end September 30, 2009. The citations are organized into cancer topic areas.

Breast Cancer

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer Epidemiology, Biomarkers and Prevention 2009 May 19.

Kapp JM, Ryerson AB, Coughlin SS, Thompson TD. Racial and ethnic differences in mammography use among U.S. women younger than age 40. Breast Cancer Research and Treatment 2009;113(2):327–337.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW. Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Research and Treatment 2009;113(2):357–370.

Miller JW, King JB, Ryerson AB, Eheman CR, White MC. Mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates. American Journal of Roentgenology 2009;192(2):352–360.

Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000–2006: A population-based analysis. Preventive Medicine 2008;47(5):477–482.

Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, Eley JW. The epidemiology of triple-negative breast cancer, including race. Cancer Causes and Control 2009 Apr 3.

Cancer Survivorship

Baili P, Micheli A, De Angelis R, Weir HK, Francisci S, Santaquilani M, Hakulinen T, Quaresmas M, Coleman MP; CONCORD Working Group. Life tables for world-wide comparison of relative survival for cancer (CONCORD study). Tumori 2008;94(5):658–668.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW. Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Research and Treatment 2009;113(2):357–370.

Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years. Cancer 2009 Aug 14.

Ross LE, Hall IJ, Fairley TL, Taylor YJ, Howard DL. Prayer and self-reported health among cancer survivors in the United States, National Health Interview Survey, 2002. Journal of Alternative and Complementary Medicine 2008;14(8):931–938.

Cervical Cancer

Castrucci BC, Echegollen Guzmán A, Saraiya M, Smith BR, Lewis KL, Coughlin SS, Gossman GL, McDonald JA, Foulkes H, Mirchandani G, Correa-Nieto Canedo L, Garcia IM, Acuña J. Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health. Preventing Chronic Disease 2008;5(4):A116.

Markowitz LE, Unger ER, Saraiya M. Primary and secondary prevention of cervical cancer—opportunities and challenges (editorial). Journal of the National Cancer Institute 2009;101(7):439–440.

Roland KB, Benard VB, Saraiya M, Hawkins NA, Brandt H, Friedman AL. Assessing cervical cancer screening guidelines in patient education materials. Journal of Women's Health 2009;18(1):5–12.

Soisson AP, Reed E, Brown P, Ducatman B, Armistead J, Kennedy S, Wang W, Kramer P, Rose S. Self-test device for cytology and HPV testing in rural Appalachian women: an evaluation. Journal of Reproductive Medicine 2008;53(6):441–448.

Colorectal Cancer

Howard DH, Tangka FK, Seeff LC, Richardson LC, Ekwueme DU. The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer. Health Economics 2009 Jan 13.

Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. American Journal of Preventive Medicine 2009;37(1):8–16.

Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115(9):1967–1976.

Rim SH, Zittleman L, Westfall JM, Overholser L, Froshaug D, Coughlin SS. Knowledge, attitudes, beliefs, and personal practices regarding colorectal cancer screening among health care professionals in rural Colorado: A pilot survey. Journal of Rural Health 2009;25(3):303–308.

Gynecologic Cancers

Macaluso M, Wright-Schnapp TJ, Chandra A, Johnson R, Satterwhite CL, Pulver A, Berman SM, Wang RY, Farr SL, Pollack LA. A public health focus on infertility prevention, detection, and management. Fertility and Sterility 2008 Nov 5. [Epub ahead of print]

Sabatino SA, Stewart SL, Wilson RJ. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001–2003. Journal of Women's Health 2009;18(3):285–294.

Soisson AP, Reed E, Brown P, Ducatman B, Armistead J, Kennedy S, Wang W, Kramer P, Rose S. Self-test device for cytology and HPV testing in rural Appalachian women: an evaluation. Journal of Reproductive Medicine 2008;53(6):441–448.

Thomas CC, Wingo PA, Dolan MS, Lee NC, Richardson LC. Endometrial cancer risk among younger, overweight women. Obstetrics and Gynecology 2009;114(1):22–27.

Health Disparities in Cancer

Kapp JM, Ryerson AB, Coughlin SS, Thompson TD. Racial and ethnic differences in mammography use among U.S. women younger than age 40. Breast Cancer Research and Treatment 2009;113(2):327–337.

Sabatino SA, Stewart SL, Wilson RJ. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001–2003. Journal of Women's Health 2009;18(3):285–294.

Soisson AP, Reed E, Brown P, Ducatman B, Armistead J, Kennedy S, Wang W, Kramer P, Rose S. Self-test device for cytology and HPV testing in rural Appalachian women: an evaluation. Journal of Reproductive Medicine 2008;53(6):441–448.

Hematologic (Blood) Cancers

Friese CR, Abel GA, Magazu LS, Neville BA, Richardson LC, Earle CC. Diagnostic delay and complications for older adults with multiple myeloma. Leukemia and Lymphoma 2009;50(3):1–9.

Human Papillomavirus (HPV)-Associated Cancers

These articles were published in the November 15, 2008 supplement edition of the journal Cancer, produced by the American Cancer Society, entitled "Assessing the Burden of HPV-Associated Cancers in the United States" (ABHACUS).

Balamurugan A, Ahmed F, Saraiya M Kosary C, Schwenn M, Cokkinides V, Flowers LC, Pollack LA. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 2008;113(S10):2919–2925.

Bates JH, Parikh-Patel A, Hofer BM. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 2008;113(S10):2955–2963.

Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, and Weir HK. Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer 2008;113(S10):2910–2918.

Castle P, Solomon D, Saslow D, Schiffman M. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States. Cancer 2008;113(S10):3031–3035.

Copeland G, Datta SD, Spivak G, Garvin AD, Cote M. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985–2003. Cancer 2008;113(S10):2946–2954.

Coughlin SS, Richards TB, Nasseri K, Weiss NS, Wiggins C, Saraiya M, Stinchcomb DG, Vensor V, Nielson C. Cervical cancer incidence in the United States in the US-Mexico border region, 1998–2003. Cancer 2008;113(S10):2964–2973.

Dunne EF, Datta SD, Markowitz L. A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer 2008;113(S10):2995–3003.

Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis—United States, 2003. Cancer 2008;113(S10):2936–2945.

Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113(S10):3036–3046.

Hernandez BY, Barnholtz-Sloan J, German RR, Giuliano AR, Goodman MT, King JB, Negoita S, Villalon-Gomez JM. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer 2008;113(S10):2883–2891.

Hopenhayn C, King JB, Christian A, Huang B, Christian WJ. Variability of cervical cancer rates across 5 Appalachian states, 1998–2003. Cancer 2008;113(S10):2974–2980.

Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, Villalon-Gomez JM, Williams M, Cress RD. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer 2008;113(S10):2892–2900.

Khan K, Curtis CR, Ekwueme DU, Stokley S, Walker C, Roland KB, Saraiya M. Preventing cervical cancer: Overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer 2008;113(S10):3004–3012.

Negoita S, Harrison JN, Qiao B, Ekwueme DU, Flowers LC, Kahn AR. Distribution of treatment for human papillomavirus-associated gynecologic carcinomas before prophylactic vaccine. Cancer 2008;113(S10):2926–2935.

Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 2008;113(S10):2901–2909.

Saraiya M, Ahmed F, White MC, Lawson H, Unger ER, Eheman CR. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US. Cancer 2008;113(S10):2837–2840.

Saraiya M, Goodman MT, Datta SD, Chen VW, Wingo P. Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: The potential role. Cancer 2008;113(S10):3047–3057.

Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, Giuliano AR. Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer 2008;113(S10):2865–2872.

Tiro JA, Saraiya M, Jain N, Liddon N, Cokkinides V, Lai SM, Breen N, Wideroff L. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 2008;113(S10):3013–3030.

Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods. Cancer 2008;113(S10):2841–2854.

Watson M, Saraiya M, Benard V, Coughlin SS, Flowers LC, Cokkinides V, Schwenn M, Huang Y, Giuliano AR. Burden of cervical cancer in the United States, 1998–2003. Cancer 2008;113(S10):2855–2864.

Whiteside MA, Siegel EM, Unger ER. Human papillomavirus and molecular considerations for cancer risk. Cancer 2008;113(S10):2981–2994.

Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 2008;113(S10):2873–2882.

Lung Cancer

Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Center MM, Ward E, Wu X, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. Journal of the National Cancer Institute 2008;100(23):1672–1694.

National Breast and Cervical Cancer Early Detection Program (NBCCEDP)

Benard VB, Howe W, Saraiya M, Helsel W, Lawson HW. Assessment of follow-up for low-grade cytological abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000–2005. Journal of Lower Genital Tract Disease 2008;12(4):300–306.

National Program of Cancer Registries (NPCR)

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer Epidemiology, Biomarkers and Prevention 2009 May 19.

Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Center MM, Ward E, Wu X, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. Journal of the National Cancer Institute 2008;100(23):1672–1694.

Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115(9):1967–1976.

Ovarian Cancer

Coates RJ, Kolor K, Stewart SL, Richardson LC. Diagnostic markers for ovarian cancer screening: Not ready for routine clinical use. Clinical Cancer Research 2008;14(22):7575–7576.

Prostate Cancer

Ross LE, Taylor YJ, Richardson LC, Howard DL. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002–2006. Journal of the National Medical Association 2009;101(4):316–324.

Skin Cancer

Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2009;150(3):194–198.

Other Research

Blossom DB, Chen TH, Li J, Langer AJ, Carpenter LR, Glenshaw MT, Gould CV, Weltman A, Srinivasan A. Self-limited febrile syndromes temporally associated with the use of propofol for sedation in gastrointestinal endoscopic procedures. Pharmacoepidemiology and Drug Safety 2009;18(4):344–348.

Goodman M, Almon L, Bayakly R, Butler S, Crosby C, Diiorio C, Ekwueme D, Fletcher D, Fowler J, Gillespie T, Glanz K, Hall I, Lee J, Liff J, Lipscomb J, Pollack LA, Richardson LC, Roberts P, Steenland K, Ward K. Cancer outcomes research in a rural area: A multi-institution partnership model. Journal of Community Health 2009;34(1):23–32.

Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Center MM, Ward E, Wu X, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. Journal of the National Cancer Institute 2008;100(23):1672–1694.

Pollack LA, Adamache W, Eheman CR, Ryerson AB, Richardson LC. Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty. Health Services Research 2009;44(2 Pt 1):562–576.

 
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Cancer Prevention and Control
    4770 Buford Hwy NE
    MS K-64
    Atlanta, GA 30341
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov

A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #